Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Bayer : shares up 1.8% trade after U.S. Roundup rule

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/16/2019 | 03:26am EDT
Headquarters and main plant of German pharmaceutical and chemical maker Bayer AG in Leverkusen

FRANKFURT (Reuters) - Shares in German chemicals company Bayer rose 1.8% in early trade on Tuesday after a U.S. judge slashed a damages award Bayer owes a California man who blamed its Roundup weed killer for his cancer.

Broker Lang & Schwarz said premarket trades had seen the stock up 4.2%. The stock had fallen 6.5% so far this month.

The judge said evidence against the former Monsanto Co, which Bayer bought last year, supported punitive damages over the glyphosate ingredient contained in Roundup but reduced damages to $20 million (£16 million) from $75 million.

A Frankfurt-based trader said that in his view early Tuesday gains were not sustainable.

"Next Glyphosate trials will start in August," he said. "Bayer will only see an ongoing recovery when it enters mediation talks to settle the 13,400 claims."

Germany's DAX <.GDAXI> was 0.06% up.

(Reporting by Vera Eckert; Editing by Thomas Seythal and Louise Heavens)

Stocks mentioned in the article
ChangeLast1st jan.
BAYER AG 2.59% 64.61 Delayed Quote.6.69%
DAX 1.31% 11562.74 Delayed Quote.9.51%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER AG
08/16Materials up Amid Hopes for Stimulus -- Materials Roundup
DJ
08/13Bayer and LANXESS to sell their stakes in Currenta to Macquarie Infrastructur..
AQ
08/12CORRECTION : Weed Killer-Label story
AQ
08/12No-deal Brexit could deepen Europe's shortage of medicines - experts
RE
08/09Materials Down After Trump Comments on Trade Negotiations -- Materials Roundu..
DJ
08/09BAYER MEDIATOR : $8 Billion Roundup Settlement Report 'Pure Fiction' -- 4th Upda..
DJ
08/09EUROPE : Italy leads European shares lower on political uncertainty
RE
08/09BAYER MEDIATOR : $8 Billion Roundup Settlement Report 'Pure Fiction' -- 3rd Upda..
DJ
08/09NEWS HIGHLIGHTS : Top Company News of the Day
DJ
08/09NEWS HIGHLIGHTS : Top Company News of the Day
DJ
More news
Financials (EUR)
Sales 2019 46 199 M
EBIT 2019 8 364 M
Net income 2019 3 352 M
Debt 2019 37 554 M
Yield 2019 4,42%
P/E ratio 2019 20,2x
P/E ratio 2020 13,7x
EV / Sales2019 2,11x
EV / Sales2020 2,00x
Capitalization 60 140 M
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 29
Average target price 77,86  €
Last Close Price 64,49  €
Spread / Highest target 90,7%
Spread / Average Target 20,7%
Spread / Lowest Target -39,9%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG6.69%65 567
JOHNSON & JOHNSON1.15%344 517
ROCHE HOLDING LTD.12.24%235 575
ROCHE HOLDING13.20%235 575
MERCK AND COMPANY11.32%213 689
NOVARTIS17.81%202 958